As of 2025-04-18, the EV/EBITDA ratio of Ionis Pharmaceuticals Inc (IONS) is -6.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IONS's latest enterprise value is 3,454.00 mil USD. IONS's TTM EBITDA according to its financial statements is -522.52 mil USD. Dividing these 2 quantities gives us the above IONS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 15.7x | 12.3x |
| Forward P/E multiples | 7.6x - 11.8x | 8.7x |
| Fair Price | (27.89) - (32.04) | (27.89) |
| Upside | -198.4% - -213.0% | -198.4% |
| Date | EV/EBITDA |
| 2025-04-16 | -6.61 |
| 2025-04-15 | -6.62 |
| 2025-04-14 | -6.71 |
| 2025-04-11 | -6.47 |
| 2025-04-10 | -6.11 |
| 2025-04-09 | -6.43 |
| 2025-04-08 | -5.75 |
| 2025-04-07 | -6.37 |
| 2025-04-04 | -6.23 |
| 2025-04-03 | -6.66 |
| 2025-04-02 | -6.72 |
| 2025-04-01 | -6.28 |
| 2025-03-31 | -7.16 |
| 2025-03-28 | -7.46 |
| 2025-03-27 | -7.64 |
| 2025-03-26 | -7.57 |
| 2025-03-25 | -7.80 |
| 2025-03-24 | -8.16 |
| 2025-03-21 | -8.00 |
| 2025-03-20 | -7.94 |
| 2025-03-19 | -8.13 |
| 2025-03-18 | -8.01 |
| 2025-03-17 | -8.42 |
| 2025-03-14 | -8.01 |
| 2025-03-13 | -7.99 |
| 2025-03-12 | -8.15 |
| 2025-03-11 | -8.03 |
| 2025-03-10 | -7.79 |
| 2025-03-07 | -8.27 |
| 2025-03-06 | -8.45 |
| 2025-03-05 | -8.25 |
| 2025-03-04 | -8.01 |
| 2025-03-03 | -7.90 |
| 2025-02-28 | -8.08 |
| 2025-02-27 | -7.52 |
| 2025-02-26 | -7.65 |
| 2025-02-25 | -7.67 |
| 2025-02-24 | -7.69 |
| 2025-02-21 | -7.82 |
| 2025-02-20 | -7.93 |
| 2025-02-19 | -7.66 |
| 2025-02-18 | -7.71 |
| 2025-02-14 | -7.43 |
| 2025-02-13 | -7.22 |
| 2025-02-12 | -7.37 |
| 2025-02-11 | -7.59 |
| 2025-02-10 | -7.56 |
| 2025-02-07 | -7.54 |
| 2025-02-06 | -7.91 |
| 2025-02-05 | -8.08 |